Appetite changes are usually the first thing people notice, often within the first weeks, and they arrive before any meaningful change on the scale. The full effect builds as the dose increases, so the early weeks are not a preview of the result. Judging the medication by month one is judging the starting dose, which was never meant to do much.
Individual response varies a great deal, and no article can tell you what yours will be. Anyone promising you a specific number by a specific week is selling something.
For how this fits into the wider titration picture, see GLP-1 Dosing and Titration: The Complete Guide.
What comes first
The earliest sign for most people is not weight. It is a change in appetite: getting full sooner, thinking about food less, finishing a meal you would previously have gone back to.
Many people describe the quieting of what is often called food noise, the running background commentary about what to eat next. When it recedes, the change is noticeable even though nothing has happened on the scale yet.
That gap between appetite change and weight change is normal and it is where most early discouragement comes from.
Why the starting dose does little
The initial dose exists to build tolerance, not to produce results. Beginning at a full dose would make most people too unwell to continue.
So the first weeks are groundwork. Weight change during them is often small, sometimes nothing, occasionally a little in either direction as fluid shifts.
This matters because it is exactly the point where people conclude it is not working and ask to escalate faster, which is the opposite of what tolerance requires.
The shape of the curve
The effect builds as the dose does, so progress is usually not linear. It commonly accelerates through the titration period, then settles into a steadier pattern.
Plateaus happen along the way and are normal rather than a sign of failure. Weight also fluctuates day to day for reasons unrelated to fat: fluid, salt, bowel habits, hormonal cycles. Weekly trends tell you far more than daily readings.
What else changes before the scale does
Worth watching, because these are real and they are often visible before weight moves much.
Clothes fitting differently. Blood pressure readings. Blood sugar, for people who monitor it. Reflux, joint discomfort, breathlessness on stairs, sleep quality.
For people treated for a condition other than weight, these are the actual endpoints, and the scale is a secondary measure.
If nothing is happening at all
Some people respond less than others, and that is a real phenomenon rather than a failure of effort.
Before concluding it is not working, check the ordinary explanations: whether you have reached a dose expected to do much yet, whether intake has quietly risen to fill the gap, and whether injection technique and storage have been sound.
If you have been at an adequate dose for a reasonable period with genuinely no change, that is a conversation with your prescriber, who can consider whether to continue, adjust or switch.
Appetite change comes before weight change, and judging the first weeks judges the starting dose. What else moves earlier is covered in weight loss by month on semaglutide. If nothing at all is happening at an adequate dose, when it seems to stop working lists what to check.
Frequently asked questions
How soon should I see something?
Appetite changes often come early; weight change lags. Judging by the first weeks is judging the starting dose.
Is it normal to lose nothing in month one?
Common, and not a sign the medication will not work for you.
Does having side effects mean it is working?
No. Side effect severity does not predict response in either direction.
Why did I gain in the first week?
Usually fluid rather than fat. Weekly trends matter more than daily readings.
Should I weigh daily or weekly?
Weekly, at the same time and in the same conditions, gives a clearer picture and less discouragement.
When should I raise it with my prescriber?
If you have been at an adequate dose for a reasonable period with no change at all, that is worth discussing rather than waiting.